Minimally Invasive Non-surgical Therapy for the Treatment of Splinted Stage IV Periodontitis
Clinical and Patient-centered Outcomes After Minimally Invasive Non-surgical Therapy for the Treatment of Splinted Stage IV Periodontitis - Randomized Controlled Clinical Trial
2 other identifiers
interventional
40
1 country
1
Brief Summary
Conventional periodontal treatment typically involves a combination of non-surgical and surgical approaches, such as scaling and root planing, followed by flap surgery and guided tissue regeneration. While these methods have demonstrated some success in managing periodontal disease, the low success rate in complex cases has prompted the exploration of alternative treatment modalities. One such approach is minimally invasive, non-surgical monotherapy, which aims to address the etiological source of the inflammation without the need for invasive surgical intervention. Guided tissue regeneration, a well-established technique in periodontal treatment, employs physical barrier membranes to exclude the proliferation of unwanted gingival fibroblasts and allow the regeneration of tooth-supporting structures such as the alveolar bone, periodontal ligament, and cementum. Recent advancements in dental therapies have led to the exploration of minimally invasive non-surgical approaches that aim to achieve comparable outcomes with reduced morbidity. This protocol outlines a randomized clinical trial to evaluate the efficacy and safety of a minimally invasive non-surgical monotherapy in treating patients with stage 4 periodontitis. Is minimally invasive non-surgical technique more effective in reducing tooth mobility and improving clinical parameters than conventional non-surgical technique?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 3, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedJanuary 14, 2025
January 1, 2025
2.3 years
January 3, 2025
January 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CAL by millimeters
Clinical attachment loss
baseline, 3months and 6 months
Study Arms (2)
conventional periodontal treatment with ultrasonic device and manual instruments
EXPERIMENTALconventional non-surgical techniques with ultrasonic and manual scaler instruments
Placebo minimally invasive non surgical technique with mini five and after five instruments
PLACEBO COMPARATORand minimally invasive non-surgical technique using mini five and after five instruments+ ultrasonic device for supragingival instrumentation
Interventions
non-surgical technique plus splint and ultrasonic device with 200 mg Tetracycline
minimally invasive instruments, with mini five and after five minimally invasive instrument ultrasonic scaler device, conventional radiographic device and periodontal instruments with post-operative 1 gram penicillin for 3 days regulatory Statement: This study does not include an FDA-regulated device intervention, as the tools utilized are not the subject of investigation but are instead employed as part of routine clinical
Eligibility Criteria
You may qualify if:
- periodontitis stage III and IV
- Mobility grade 2
- age from 18-55 years
- medically free
- nonsmoker
- Single-rooted teeth
You may not qualify if:
- Medically compromised patient
- smokers
- Bad oral hygiene
- Non-surgical or surgical periodontal treatment in the past 12months.
- Prolonged treatment with antibiotics or anti-inflammatory agents within 6months before periodontal therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Egypt
Cairo, Beni Suweif Governorate, 12345, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- investigator
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer in department of periodontology
Study Record Dates
First Submitted
January 3, 2025
First Posted
January 13, 2025
Study Start
August 11, 2022
Primary Completion
November 11, 2024
Study Completion
November 30, 2024
Last Updated
January 14, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
after publishing, i will share it